📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Pembrolizumab in Patients With Advanced Clear Cell Gynecological Cancer: A Phase 2 Nonrandomized Clinical Trial. (2025)

First Author: Kristeleit R

Attributed to: Immunotherapy and clear cell ovarian cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1001/jamaoncol.2024.6797

PubMed Identifier: 39913118

Publication URI: http://europepmc.org/abstract/MED/39913118

Type: Journal Article/Review

Parent Publication: JAMA oncology

ISSN: 2374-2437